Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-bromopropionyl Chloride
2. 15486-96-1
3. 3-bromopropanoyl Chloride
4. Einecs 239-515-2
5. Dtxsid3065900
6. Refchem:869598
7. Dtxcid0034988
8. 239-515-2
9. Mfcd00000746
10. 3-bromopropionic Acid Chloride
11. 3-bromopropanoyl Chloride; 3-bromopropanoic Acid Chloride; Beta-bromopropanoyl Chloride; ?-bromopropanoyl Chloride; Beta-bromopropionyl Chloride
12. 3-bromoproionylchloride
13. 3-bromopropanoylchloride
14. 3-bromopropionylchloride
15. 3-bromo Propionylchloride
16. 3-bromopropionic Chloride
17. 3-bromopropionoyl Chloride
18. 3-bromo-propanoyl Chloride
19. 3-bromo-propionyl Chloride
20. Beta-bromopropionyl Chloride
21. 3-bromopropanoyl Chloride #
22. Schembl34044
23. .beta.-bromopropionyl Chloride
24. Bbl011521
25. Stl146637
26. Akos005720747
27. Sy035526
28. Vs-02968
29. 3-bromopropionyl Chloride, Technical Grade
30. Db-043248
31. B2065
32. Ns00025032
33. D88890
34. En300-132996
| Molecular Weight | 171.42 g/mol |
|---|---|
| Molecular Formula | C3H4BrClO |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 17.1 |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 54.8 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of B2065 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right B2065 manufacturer or B2065 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred B2065 manufacturer or B2065 supplier.
A B2065 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of B2065, including repackagers and relabelers. The FDA regulates B2065 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. B2065 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A B2065 supplier is an individual or a company that provides B2065 active pharmaceutical ingredient (API) or B2065 finished formulations upon request. The B2065 suppliers may include B2065 API manufacturers, exporters, distributors and traders.
B2065 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of B2065 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right B2065 GMP manufacturer or B2065 GMP API supplier for your needs.
A B2065 CoA (Certificate of Analysis) is a formal document that attests to B2065's compliance with B2065 specifications and serves as a tool for batch-level quality control.
B2065 CoA mostly includes findings from lab analyses of a specific batch. For each B2065 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
B2065 may be tested according to a variety of international standards, such as European Pharmacopoeia (B2065 EP), B2065 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (B2065 USP).
